InflaRx (IFRX) Cash & Equivalents (2016 - 2026)
InflaRx (IFRX) posted Cash & Equivalents of $170.36 million for Q2 2026, compared with $14.72 million a year earlier and up 870.5% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, InflaRx's Cash & Equivalents came in at $18.1 million, down 7.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
- In prior years, InflaRx's Cash & Equivalents was $19.64 million in FY2024 (+42.9%), $13.74 million in FY2023 (-17.2%), $16.59 million in FY2022 (-44.7%) and $30.03 million in FY2021 (-3.0%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q2 2018.
- On a year-over-year basis, Cash & Equivalents increased in three of the last seven quarters, with an average decline of 3.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2025, with growth of 82.4%; the weakest was Q1 2023, with a decline of 95.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $17.55 million (Q1 2026), $18.65 million (Q4 2025) and $7.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | InflaRx | 105.31 Mn | -228.31 Mn | 2.74 Mn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.41 Mn |
| Mar 31, 2026 | 17.18 Mn |
| Dec 31, 2025 | 18.82 Mn |
| Sep 30, 2025 | 7.56 Mn |
| Jun 30, 2025 | 15.25 Mn |
| Mar 31, 2025 | 51.18 Mn |
| Dec 31, 2024 | 19.15 Mn |
| Sep 30, 2024 | 29.27 Mn |
| Jun 30, 2024 | 20.51 Mn |
| Mar 31, 2024 | 27.10 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | 22.92 Mn |
| Jun 30, 2023 | 21.21 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 17.34 Mn |
| Sep 30, 2022 | 17.67 Mn |
| Jun 30, 2022 | 16.10 Mn |
| Mar 31, 2022 | 44.75 Mn |
| Dec 31, 2021 | 29.73 Mn |
| Sep 30, 2021 | 81.17 Mn |
API Access
InflaRx Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();